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SHORT REPORT
Endometrial polyps in postmenopausal women
ANA PATRI´CIA DOMINGUES1, HELENA LOPES1, ISABEL DIAS1 & CARLOS FREIRE
DE OLIVEIRA1,2
1Department of Gynecology, Coimbra University Hospitals, Coimbra, Portugal, and 2Gynecological Clinic of the Faculty of
Medicine, Coimbra University, Coimbra, Portugal
Abstract
The malignancy risk of endometrial polyps in postmenopausal women was correlated with the presence or absence of
abnormal uterine bleeding. Of 481 postmenopausal women who presented with endometrial polyps at diagnostic
hysteroscopy between 2004 and 2007, 48.9% were asymptomatic and 51.1% had postmenopausal uterine bleeding.
Transvaginal ultrasound revealed abnormal endometrial thickness in 60.0% vs. 57.7%, polyps in 37.9% vs. 32.9%,
endometrial tumors in 1.3% vs. 0.8%, and submucosal myomas in 0.9% vs. 2.0% by the absence or presence of bleeding.
Around three-fourth of the polyps were removed. Histopathologic diagnoses showed mucous polyps in 93.7 of
asymptomatic women compared to 80.7% of those with bleeding, while endometrial tumors were only seen in those
bleeding (7.2%). The malignancy risk within endometrial polyps in postmenopausal women varies with the presence of
vaginal bleeding, and is minimal in asymptomatic women.
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Introduction
The introduction of transvaginal ultrasound in
routine gynecological practice has increased the
number of asymptomatic lesions identified in post-
menopausal women (14). The prevalence of en-
dometrial polyps is unknown because they
frequently occur without associated symptomatol-
ogy, but in women with abnormal bleeding, it has
been reported to range from 13% to 50% (3). Even
though most lesions are benign, some are pre-
malignant (simple or complex hyperplasia with
cytological atypia) or malignant (endometrial can-
cer) (2). Although the malignancy potential of
endometrial polyps is uncertain, they are believed
to be a risk factor for endometrial cancer and the
actual incidence of malignancy detected in endome-
trial polyps has ranged between 0.5% and 4.8%
(1,4). The entire suspicious lesion can be removed
under direct vision by hysteroscopic polypectomy,
which is generally regarded as the ‘gold standard’ for
the diagnosis of polyps (2,4) and recommended for
symptomatic patients. A similar approach is reason-
able for asymptomatic polyps in postmenopausal
women to disprove a malignant condition, although
this procedure is arguable (1,3,4).
The objective of this study was to evaluate the risk
of malignancy of endometrial polyps in postmeno-
pausal women according to the presence or absence
of symptomatology.
Material and methods
From the Departmental hysteroscopy database, we
selected all 481 postmenopausal women who under-
went a diagnostic hysteroscopy between 2004 and
2007 and were diagnosed with endometrial polyps.
We considered postmenopausal women older than
40 years who had cessation of menstrual period more
than 12 months before, and abnormal uterine
bleeding was considered to be any uterine bleeding
thereafter.
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All patients were referred for diagnostic hystero-
scopy because of abnormal uterine bleeding or an
abnormal transvaginal ultrasound finding. The wo-
men were considered in two groups: those with
episodes of postmenopausal bleeding and those
asymptomatic. From the medical records, data
were collected on age, menopausal age, use of
hormonal therapy, and medical conditions asso-
ciated with endometrial cancer risk (hypertension,
diabetes). Transvaginal ultrasound findings before
hysteroscopy were evaluated for both groups.
Operative hysteroscopy was proposed to all pa-
tients, usually as an ambulatory procedure; but when
not possible/tolerated/accepted by the patient, a
surgical hysteroscopy was done under general an-
esthesia, using a 9 mM Storz resectoscope. The
identified lesion was completely removed. Histolo-
gical results in both groups were compared.
The data were analyzed using SPSS version 15.0,
with chi-squared test for qualitative and the t-test for
quantitative variables. A value of pB0.05 was
considered significant. Logistic regression analysis
was used to determine adjusted odds ratios and 95%
confidence intervals of abnormal uterine bleeding,
hormonal therapy use, hypertension, and diabetes
on tumor incidence.
Results
Of the women, 48.9% were asymptomatic and 51.1%
had postmenopausal uterine bleeding. Mean age at
diagnosis was (asymptomatic vs. symptomatic)
63.198.3 vs. 62.799.7 years and menopausal
mean age 50.094.2 vs. 49.694.4 years. Of the
women, 15.2% vs. 17.7% had hypertension and
4.4% vs. 4.2% had diabetes, a non-significant
difference. Hormonal therapy was used by 5.6% of
the asymptomatic women and by 11% of those
symptomatic (p0.001). The pre-treatment trans-
vaginal ultrasound findings are summarized in
Table I. Diagnosed polyps were surgically removed
in, respectively, 74.5% vs. 73.6% of the women. In
the remaining cases, removal was either performed
outside our department or refused by the patients.
The histopathologic results of the removed polyps
(Table I) revealed mucous polyps in 93.7% of the
asymptomatic women and 80.7% of those bleeding.
Endometrial tumor material was only noted in the
symptomatic group (7.2%; pB0.0001), and cytolo-
gical atypia was also more frequent in this group
(2.2%, p0.021). Logistic regression analysis
showed a significant increase (pB0.0001) in the
incidence of malignancy in the polyps of women who
presented with abnormal uterine bleeding (when
compared to asymptomatic group), but no signifi-
cant influence of hormone replacement therapy
(HRT) (p0.247; OR 0.34, 95% CI: 0.042.65),
hypertension (p0.367; OR 1.37, 95% CI: 0.49
3.86) or diabetes (p0.414; OR 1.54, 95% CI:
0.337.13). For the incidence of pre-malignancy in
polyps, analysis also showed significant influence of
postmenopausal bleeding (p0.021; OR 8.05, 95%
CI: 0.9965.02), but no significant influence of
HRT (p0.535; OR 0.61, 95% CI: 0.084.97),
Table I. Overview of the results obtained according to the presence of uterine bleeding.
Asymptomatic Symptomatic p
N481 235 48.9% 246 51.1%
Transvaginal ultrasound
Endometrial thickness 141 60.0% 142 57.7%
Polyp 89 37.9% 81 32.9%
Endometrial tumor 3 1.3% 2 0.8%
Submucousal myoma 2 0.9% 5 2.0%
Polypectomy
175 74.5% 181 73.6%
Histopathologic results
Mucous polyps 164 93.7% 146 80.7%
Endometrial tumors 0 0% 13 7.2% B0.0001
Cystic hyperplasia
Complex 1 0.6% 1 0.6%
Simple 1 0.6% 8 4.4%
With cytological atypia 1 0.6% 8 4.4% 0.021
Normal endometrium 3 1.7% 1 0.6%
Cystic atrophy of the endometrium 2 1.1% 1 0.6%
Atrophic endometrium 2 1.1% 2 1.1%
Submucousal myoma 1 0.6% 4 2.2%



































hypertension (p0.499; OR 0.77, 95% CI: 0.19
3.21), or diabetes (p0.199; OR 2.91, 95% CI:
0.5814.63).
Discussion
The rate of malignancy in endometrial polyps, i.e. 13
cases or 2.7% of the total study population, was
within the range reported of 0.84.8% (36).
Although uterine bleeding as a predictive factor for
malignancy in endometrial polyps has not been
universally reported (4), and risk of pre-malignancy
and malignancy within endometrial polyps in post-
menopausal women differed, in our study similar to
others the risk was significantly higher in the
symptomatic group with the presence of vaginal
bleeding (3,5,7).
We also observed that the risk of a pre-malignant
or malignant lesion in a polyp was not affected by
use of HRT or by the presence of others risks factors
for malignancy, such as hypertension or diabetes,
consistent with other authors (4,5). Considering
this, operative hysteroscopy with complete removal
of the polyp (a safe procedure in this age group)
should be offered to all symptomatic patients,
regardless of the presence or absence of risk factors
(1,2,5).
The evaluation of polyps in asymptomatic women
may allow the detection of pre-malignant conditions
and an earlier diagnosis of endometrial carcinoma
(1). The presence of malignancy in extracted polyps
of this group of women was reported in one large
study, but it included a heterogeneous population of
pre- and postmenopausal patients (1,5). A decision
to remove asymptomatic polyps in postmenopausal
women must take into consideration certain factors
like the inherent risk of malignancy or pre-malignant
pathology, the potential malignant transformation of
benign incidental polyps over the years if left in situ
and the risks of the procedure itself (1).
In women with a high operative risk, conservative
management may be a safe option (1,2,4). The
results of this study suggest that in asymptomatic
postmenopausal women with endometrial polyps
confirmed by hysteroscopy, in whom ambulatory or
programmed operative hysteroscopy is not possible,
transvaginal ultrasound or diagnostic hysteroscopy
in a regular surveillance scheme are alternative
options to surgery, being a safe procedure and
reducing surgical morbidity.
Disclosure of interests: The authors report no
conflicts of interest. The authors alone are respon-
sible for the content and writing of the paper.
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